nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100B—Alzheimer's disease	0.632	1	CbGaD
Olopatadine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0407	0.432	CbGbCtD
Olopatadine—CYP3A4—Donepezil—Alzheimer's disease	0.0325	0.345	CbGbCtD
Olopatadine—CYP3A4—Galantamine—Alzheimer's disease	0.021	0.223	CbGbCtD
Olopatadine—Eyelid disorder—Rivastigmine—Alzheimer's disease	0.00745	0.0681	CcSEcCtD
Olopatadine—Postnasal drip—Donepezil—Alzheimer's disease	0.0068	0.0621	CcSEcCtD
Olopatadine—S100B—blood vessel—Alzheimer's disease	0.00648	0.134	CbGeAlD
Olopatadine—Upper-airway cough syndrome—Donepezil—Alzheimer's disease	0.00576	0.0526	CcSEcCtD
Olopatadine—Blepharospasm—Rivastigmine—Alzheimer's disease	0.00397	0.0362	CcSEcCtD
Olopatadine—S100A1—forebrain—Alzheimer's disease	0.00396	0.0816	CbGeAlD
Olopatadine—S100A1—telencephalon—Alzheimer's disease	0.00364	0.075	CbGeAlD
Olopatadine—S100B—forebrain—Alzheimer's disease	0.00342	0.0705	CbGeAlD
Olopatadine—S100B—telencephalon—Alzheimer's disease	0.00315	0.0648	CbGeAlD
Olopatadine—S100A1—nervous system—Alzheimer's disease	0.00215	0.0443	CbGeAlD
Olopatadine—S100A1—central nervous system—Alzheimer's disease	0.00207	0.0426	CbGeAlD
Olopatadine—S100A1—cerebellum—Alzheimer's disease	0.00202	0.0417	CbGeAlD
Olopatadine—S100A13—nervous system—Alzheimer's disease	0.00191	0.0393	CbGeAlD
Olopatadine—S100B—nervous system—Alzheimer's disease	0.00186	0.0383	CbGeAlD
Olopatadine—S100A13—central nervous system—Alzheimer's disease	0.00184	0.0378	CbGeAlD
Olopatadine—S100A13—cerebellum—Alzheimer's disease	0.00179	0.037	CbGeAlD
Olopatadine—S100B—central nervous system—Alzheimer's disease	0.00179	0.0368	CbGeAlD
Olopatadine—S100A2—brain—Alzheimer's disease	0.00178	0.0368	CbGeAlD
Olopatadine—S100B—cerebellum—Alzheimer's disease	0.00175	0.036	CbGeAlD
Olopatadine—S100A1—brain—Alzheimer's disease	0.00164	0.0339	CbGeAlD
Olopatadine—Visual acuity reduced—Memantine—Alzheimer's disease	0.00161	0.0147	CcSEcCtD
Olopatadine—S100A13—brain—Alzheimer's disease	0.00146	0.03	CbGeAlD
Olopatadine—S100A12—brain—Alzheimer's disease	0.00144	0.0296	CbGeAlD
Olopatadine—S100B—brain—Alzheimer's disease	0.00142	0.0292	CbGeAlD
Olopatadine—Eye irritation—Donepezil—Alzheimer's disease	0.00123	0.0113	CcSEcCtD
Olopatadine—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00116	0.0106	CcSEcCtD
Olopatadine—Stinging—Rivastigmine—Alzheimer's disease	0.00115	0.0105	CcSEcCtD
Olopatadine—Cough increased—Donepezil—Alzheimer's disease	0.00115	0.0105	CcSEcCtD
Olopatadine—Dry eye—Donepezil—Alzheimer's disease	0.000972	0.00888	CcSEcCtD
Olopatadine—Dermatitis contact—Rivastigmine—Alzheimer's disease	0.000924	0.00844	CcSEcCtD
Olopatadine—Thirst—Donepezil—Alzheimer's disease	0.000803	0.00733	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.000792	0.00723	CcSEcCtD
Olopatadine—Eye pain—Memantine—Alzheimer's disease	0.000768	0.00702	CcSEcCtD
Olopatadine—Depression—Galantamine—Alzheimer's disease	0.000757	0.00692	CcSEcCtD
Olopatadine—Eye pain—Rivastigmine—Alzheimer's disease	0.000752	0.00686	CcSEcCtD
Olopatadine—Urinary tract infection—Galantamine—Alzheimer's disease	0.000738	0.00674	CcSEcCtD
Olopatadine—Epistaxis—Galantamine—Alzheimer's disease	0.000716	0.00654	CcSEcCtD
Olopatadine—Thirst—Rivastigmine—Alzheimer's disease	0.000713	0.00651	CcSEcCtD
Olopatadine—HRH1—forebrain—Alzheimer's disease	0.000701	0.0145	CbGeAlD
Olopatadine—Dry skin—Donepezil—Alzheimer's disease	0.0007	0.00639	CcSEcCtD
Olopatadine—Rhinitis—Galantamine—Alzheimer's disease	0.000684	0.00624	CcSEcCtD
Olopatadine—Nasopharyngitis—Donepezil—Alzheimer's disease	0.000683	0.00624	CcSEcCtD
Olopatadine—Influenza—Donepezil—Alzheimer's disease	0.00066	0.00603	CcSEcCtD
Olopatadine—Visual impairment—Galantamine—Alzheimer's disease	0.000657	0.006	CcSEcCtD
Olopatadine—HRH1—telencephalon—Alzheimer's disease	0.000645	0.0133	CbGeAlD
Olopatadine—Eye disorder—Galantamine—Alzheimer's disease	0.000637	0.00582	CcSEcCtD
Olopatadine—Dry skin—Memantine—Alzheimer's disease	0.000636	0.00581	CcSEcCtD
Olopatadine—Dry skin—Rivastigmine—Alzheimer's disease	0.000622	0.00568	CcSEcCtD
Olopatadine—Nasopharyngitis—Memantine—Alzheimer's disease	0.00062	0.00566	CcSEcCtD
Olopatadine—Immune system disorder—Galantamine—Alzheimer's disease	0.000616	0.00562	CcSEcCtD
Olopatadine—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.000607	0.00554	CcSEcCtD
Olopatadine—Weight increased—Donepezil—Alzheimer's disease	0.000601	0.00549	CcSEcCtD
Olopatadine—Influenza—Memantine—Alzheimer's disease	0.000599	0.00547	CcSEcCtD
Olopatadine—Infestation NOS—Donepezil—Alzheimer's disease	0.000589	0.00538	CcSEcCtD
Olopatadine—Infestation—Donepezil—Alzheimer's disease	0.000589	0.00538	CcSEcCtD
Olopatadine—Depression—Donepezil—Alzheimer's disease	0.000587	0.00536	CcSEcCtD
Olopatadine—Dysgeusia—Galantamine—Alzheimer's disease	0.000581	0.00531	CcSEcCtD
Olopatadine—Back pain—Galantamine—Alzheimer's disease	0.000574	0.00524	CcSEcCtD
Olopatadine—Urinary tract infection—Donepezil—Alzheimer's disease	0.000572	0.00523	CcSEcCtD
Olopatadine—Conjunctivitis—Donepezil—Alzheimer's disease	0.000572	0.00523	CcSEcCtD
Olopatadine—Muscle spasms—Galantamine—Alzheimer's disease	0.000571	0.00521	CcSEcCtD
Olopatadine—Vision blurred—Galantamine—Alzheimer's disease	0.000559	0.00511	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.000557	0.00509	CcSEcCtD
Olopatadine—Epistaxis—Donepezil—Alzheimer's disease	0.000555	0.00507	CcSEcCtD
Olopatadine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000551	0.00503	CcSEcCtD
Olopatadine—Weight increased—Memantine—Alzheimer's disease	0.000545	0.00498	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000545	0.00498	CcSEcCtD
Olopatadine—Malaise—Galantamine—Alzheimer's disease	0.000535	0.00489	CcSEcCtD
Olopatadine—Infestation NOS—Memantine—Alzheimer's disease	0.000534	0.00488	CcSEcCtD
Olopatadine—Infestation—Memantine—Alzheimer's disease	0.000534	0.00488	CcSEcCtD
Olopatadine—Weight increased—Rivastigmine—Alzheimer's disease	0.000534	0.00487	CcSEcCtD
Olopatadine—Depression—Memantine—Alzheimer's disease	0.000533	0.00487	CcSEcCtD
Olopatadine—Rhinitis—Donepezil—Alzheimer's disease	0.00053	0.00484	CcSEcCtD
Olopatadine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000526	0.0048	CcSEcCtD
Olopatadine—Pharyngitis—Donepezil—Alzheimer's disease	0.000524	0.00479	CcSEcCtD
Olopatadine—Infestation—Rivastigmine—Alzheimer's disease	0.000523	0.00477	CcSEcCtD
Olopatadine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000523	0.00477	CcSEcCtD
Olopatadine—Depression—Rivastigmine—Alzheimer's disease	0.000521	0.00476	CcSEcCtD
Olopatadine—Urinary tract infection—Memantine—Alzheimer's disease	0.000519	0.00474	CcSEcCtD
Olopatadine—Conjunctivitis—Memantine—Alzheimer's disease	0.000519	0.00474	CcSEcCtD
Olopatadine—Cough—Galantamine—Alzheimer's disease	0.000518	0.00473	CcSEcCtD
Olopatadine—Visual impairment—Donepezil—Alzheimer's disease	0.000509	0.00465	CcSEcCtD
Olopatadine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000508	0.00464	CcSEcCtD
Olopatadine—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000508	0.00464	CcSEcCtD
Olopatadine—Epistaxis—Memantine—Alzheimer's disease	0.000504	0.0046	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000502	0.00458	CcSEcCtD
Olopatadine—Sinusitis—Memantine—Alzheimer's disease	0.000501	0.00458	CcSEcCtD
Olopatadine—Discomfort—Galantamine—Alzheimer's disease	0.000499	0.00456	CcSEcCtD
Olopatadine—Dry mouth—Galantamine—Alzheimer's disease	0.000494	0.00451	CcSEcCtD
Olopatadine—Epistaxis—Rivastigmine—Alzheimer's disease	0.000493	0.0045	CcSEcCtD
Olopatadine—Sinusitis—Rivastigmine—Alzheimer's disease	0.000491	0.00448	CcSEcCtD
Olopatadine—Rhinitis—Memantine—Alzheimer's disease	0.000481	0.00439	CcSEcCtD
Olopatadine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000477	0.00436	CcSEcCtD
Olopatadine—Pharyngitis—Memantine—Alzheimer's disease	0.000476	0.00435	CcSEcCtD
Olopatadine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000475	0.00434	CcSEcCtD
Olopatadine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000471	0.0043	CcSEcCtD
Olopatadine—Skin disorder—Galantamine—Alzheimer's disease	0.000471	0.0043	CcSEcCtD
Olopatadine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000467	0.00426	CcSEcCtD
Olopatadine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000466	0.00425	CcSEcCtD
Olopatadine—Visual impairment—Memantine—Alzheimer's disease	0.000462	0.00422	CcSEcCtD
Olopatadine—Amitriptyline—NTRK2—Alzheimer's disease	0.000462	0.102	CrCbGaD
Olopatadine—Erythema—Donepezil—Alzheimer's disease	0.00046	0.0042	CcSEcCtD
Olopatadine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000452	0.00413	CcSEcCtD
Olopatadine—Dysgeusia—Donepezil—Alzheimer's disease	0.00045	0.00411	CcSEcCtD
Olopatadine—Eye disorder—Memantine—Alzheimer's disease	0.000448	0.00409	CcSEcCtD
Olopatadine—Back pain—Donepezil—Alzheimer's disease	0.000445	0.00406	CcSEcCtD
Olopatadine—Muscle spasms—Donepezil—Alzheimer's disease	0.000442	0.00404	CcSEcCtD
Olopatadine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000439	0.00401	CcSEcCtD
Olopatadine—Vision blurred—Donepezil—Alzheimer's disease	0.000434	0.00396	CcSEcCtD
Olopatadine—Immune system disorder—Memantine—Alzheimer's disease	0.000433	0.00396	CcSEcCtD
Olopatadine—Mediastinal disorder—Memantine—Alzheimer's disease	0.000432	0.00395	CcSEcCtD
Olopatadine—Somnolence—Galantamine—Alzheimer's disease	0.000431	0.00393	CcSEcCtD
Olopatadine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000427	0.0039	CcSEcCtD
Olopatadine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000423	0.00386	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000418	0.00382	CcSEcCtD
Olopatadine—Fatigue—Galantamine—Alzheimer's disease	0.000418	0.00381	CcSEcCtD
Olopatadine—Malaise—Donepezil—Alzheimer's disease	0.000415	0.00379	CcSEcCtD
Olopatadine—Dysgeusia—Memantine—Alzheimer's disease	0.000409	0.00374	CcSEcCtD
Olopatadine—Erythema—Rivastigmine—Alzheimer's disease	0.000409	0.00373	CcSEcCtD
Olopatadine—Back pain—Memantine—Alzheimer's disease	0.000404	0.00369	CcSEcCtD
Olopatadine—Cough—Donepezil—Alzheimer's disease	0.000401	0.00367	CcSEcCtD
Olopatadine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.0004	0.00365	CcSEcCtD
Olopatadine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000399	0.00365	CcSEcCtD
Olopatadine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000396	0.00362	CcSEcCtD
Olopatadine—Back pain—Rivastigmine—Alzheimer's disease	0.000395	0.00361	CcSEcCtD
Olopatadine—Vision blurred—Memantine—Alzheimer's disease	0.000394	0.00359	CcSEcCtD
Olopatadine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000393	0.00359	CcSEcCtD
Olopatadine—Thiothixene—HTR6—Alzheimer's disease	0.000388	0.0854	CrCbGaD
Olopatadine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000388	0.00354	CcSEcCtD
Olopatadine—Discomfort—Donepezil—Alzheimer's disease	0.000387	0.00353	CcSEcCtD
Olopatadine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000385	0.00352	CcSEcCtD
Olopatadine—Dry mouth—Donepezil—Alzheimer's disease	0.000383	0.0035	CcSEcCtD
Olopatadine—Body temperature increased—Galantamine—Alzheimer's disease	0.000383	0.0035	CcSEcCtD
Olopatadine—Abdominal pain—Galantamine—Alzheimer's disease	0.000383	0.0035	CcSEcCtD
Olopatadine—HRH1—nervous system—Alzheimer's disease	0.000381	0.00785	CbGeAlD
Olopatadine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000379	0.00346	CcSEcCtD
Olopatadine—Malaise—Memantine—Alzheimer's disease	0.000377	0.00344	CcSEcCtD
Olopatadine—Oedema—Donepezil—Alzheimer's disease	0.000375	0.00343	CcSEcCtD
Olopatadine—Infection—Donepezil—Alzheimer's disease	0.000373	0.00341	CcSEcCtD
Olopatadine—Malaise—Rivastigmine—Alzheimer's disease	0.000368	0.00336	CcSEcCtD
Olopatadine—Nervous system disorder—Donepezil—Alzheimer's disease	0.000368	0.00336	CcSEcCtD
Olopatadine—HRH1—central nervous system—Alzheimer's disease	0.000367	0.00755	CbGeAlD
Olopatadine—Cough—Memantine—Alzheimer's disease	0.000364	0.00333	CcSEcCtD
Olopatadine—Hypersensitivity—Galantamine—Alzheimer's disease	0.000357	0.00326	CcSEcCtD
Olopatadine—Cough—Rivastigmine—Alzheimer's disease	0.000357	0.00326	CcSEcCtD
Olopatadine—Discomfort—Memantine—Alzheimer's disease	0.000351	0.00321	CcSEcCtD
Olopatadine—Dry mouth—Memantine—Alzheimer's disease	0.000348	0.00318	CcSEcCtD
Olopatadine—Asthenia—Galantamine—Alzheimer's disease	0.000348	0.00317	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000345	0.00315	CcSEcCtD
Olopatadine—Discomfort—Rivastigmine—Alzheimer's disease	0.000344	0.00314	CcSEcCtD
Olopatadine—Oedema—Memantine—Alzheimer's disease	0.000341	0.00311	CcSEcCtD
Olopatadine—Dry mouth—Rivastigmine—Alzheimer's disease	0.00034	0.00311	CcSEcCtD
Olopatadine—Infection—Memantine—Alzheimer's disease	0.000339	0.00309	CcSEcCtD
Olopatadine—Dyspnoea—Donepezil—Alzheimer's disease	0.000335	0.00306	CcSEcCtD
Olopatadine—Nervous system disorder—Memantine—Alzheimer's disease	0.000334	0.00305	CcSEcCtD
Olopatadine—Somnolence—Donepezil—Alzheimer's disease	0.000334	0.00305	CcSEcCtD
Olopatadine—Oedema—Rivastigmine—Alzheimer's disease	0.000333	0.00305	CcSEcCtD
Olopatadine—Diarrhoea—Galantamine—Alzheimer's disease	0.000331	0.00303	CcSEcCtD
Olopatadine—Infection—Rivastigmine—Alzheimer's disease	0.000331	0.00303	CcSEcCtD
Olopatadine—Skin disorder—Memantine—Alzheimer's disease	0.000331	0.00302	CcSEcCtD
Olopatadine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000327	0.00299	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000324	0.00296	CcSEcCtD
Olopatadine—Skin disorder—Rivastigmine—Alzheimer's disease	0.000324	0.00296	CcSEcCtD
Olopatadine—Fatigue—Donepezil—Alzheimer's disease	0.000324	0.00296	CcSEcCtD
Olopatadine—Pain—Donepezil—Alzheimer's disease	0.000321	0.00293	CcSEcCtD
Olopatadine—Dizziness—Galantamine—Alzheimer's disease	0.00032	0.00293	CcSEcCtD
Olopatadine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000309	0.00283	CcSEcCtD
Olopatadine—Vomiting—Galantamine—Alzheimer's disease	0.000308	0.00281	CcSEcCtD
Olopatadine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000307	0.0028	CcSEcCtD
Olopatadine—Clomipramine—HTR6—Alzheimer's disease	0.000307	0.0675	CrCbGaD
Olopatadine—Chlorprothixene—HTR6—Alzheimer's disease	0.000306	0.0672	CrCbGaD
Olopatadine—Rash—Galantamine—Alzheimer's disease	0.000305	0.00279	CcSEcCtD
Olopatadine—Dermatitis—Galantamine—Alzheimer's disease	0.000305	0.00279	CcSEcCtD
Olopatadine—Dyspnoea—Memantine—Alzheimer's disease	0.000304	0.00278	CcSEcCtD
Olopatadine—Headache—Galantamine—Alzheimer's disease	0.000303	0.00277	CcSEcCtD
Olopatadine—Somnolence—Memantine—Alzheimer's disease	0.000303	0.00277	CcSEcCtD
Olopatadine—Nortriptyline—HTR6—Alzheimer's disease	0.0003	0.066	CrCbGaD
Olopatadine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000297	0.00271	CcSEcCtD
Olopatadine—Body temperature increased—Donepezil—Alzheimer's disease	0.000297	0.00271	CcSEcCtD
Olopatadine—Abdominal pain—Donepezil—Alzheimer's disease	0.000297	0.00271	CcSEcCtD
Olopatadine—Somnolence—Rivastigmine—Alzheimer's disease	0.000296	0.00271	CcSEcCtD
Olopatadine—CYP3A4—nervous system—Alzheimer's disease	0.000294	0.00607	CbGeAlD
Olopatadine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000294	0.00269	CcSEcCtD
Olopatadine—Fatigue—Memantine—Alzheimer's disease	0.000294	0.00268	CcSEcCtD
Olopatadine—Pain—Memantine—Alzheimer's disease	0.000291	0.00266	CcSEcCtD
Olopatadine—HRH1—brain—Alzheimer's disease	0.000291	0.006	CbGeAlD
Olopatadine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000288	0.00263	CcSEcCtD
Olopatadine—Nausea—Galantamine—Alzheimer's disease	0.000288	0.00263	CcSEcCtD
Olopatadine—Fatigue—Rivastigmine—Alzheimer's disease	0.000287	0.00263	CcSEcCtD
Olopatadine—Pain—Rivastigmine—Alzheimer's disease	0.000285	0.0026	CcSEcCtD
Olopatadine—CYP3A4—central nervous system—Alzheimer's disease	0.000283	0.00584	CbGeAlD
Olopatadine—Feeling abnormal—Memantine—Alzheimer's disease	0.000281	0.00257	CcSEcCtD
Olopatadine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000279	0.00255	CcSEcCtD
Olopatadine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000277	0.00253	CcSEcCtD
Olopatadine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000275	0.00251	CcSEcCtD
Olopatadine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000273	0.00249	CcSEcCtD
Olopatadine—Abdominal pain—Memantine—Alzheimer's disease	0.000269	0.00246	CcSEcCtD
Olopatadine—Body temperature increased—Memantine—Alzheimer's disease	0.000269	0.00246	CcSEcCtD
Olopatadine—Asthenia—Donepezil—Alzheimer's disease	0.000269	0.00246	CcSEcCtD
Olopatadine—Doxepin—HTR6—Alzheimer's disease	0.000269	0.0592	CrCbGaD
Olopatadine—Pruritus—Donepezil—Alzheimer's disease	0.000266	0.00243	CcSEcCtD
Olopatadine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000264	0.00241	CcSEcCtD
Olopatadine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000264	0.00241	CcSEcCtD
Olopatadine—Diarrhoea—Donepezil—Alzheimer's disease	0.000257	0.00235	CcSEcCtD
Olopatadine—Hypersensitivity—Memantine—Alzheimer's disease	0.000251	0.00229	CcSEcCtD
Olopatadine—Dizziness—Donepezil—Alzheimer's disease	0.000248	0.00227	CcSEcCtD
Olopatadine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000246	0.00224	CcSEcCtD
Olopatadine—Asthenia—Memantine—Alzheimer's disease	0.000245	0.00223	CcSEcCtD
Olopatadine—Pruritus—Memantine—Alzheimer's disease	0.000241	0.0022	CcSEcCtD
Olopatadine—Asthenia—Rivastigmine—Alzheimer's disease	0.000239	0.00218	CcSEcCtD
Olopatadine—Vomiting—Donepezil—Alzheimer's disease	0.000239	0.00218	CcSEcCtD
Olopatadine—Rash—Donepezil—Alzheimer's disease	0.000237	0.00216	CcSEcCtD
Olopatadine—Dermatitis—Donepezil—Alzheimer's disease	0.000236	0.00216	CcSEcCtD
Olopatadine—Pruritus—Rivastigmine—Alzheimer's disease	0.000236	0.00215	CcSEcCtD
Olopatadine—Headache—Donepezil—Alzheimer's disease	0.000235	0.00215	CcSEcCtD
Olopatadine—Diarrhoea—Memantine—Alzheimer's disease	0.000233	0.00213	CcSEcCtD
Olopatadine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000228	0.00208	CcSEcCtD
Olopatadine—Dizziness—Memantine—Alzheimer's disease	0.000225	0.00206	CcSEcCtD
Olopatadine—Nausea—Donepezil—Alzheimer's disease	0.000223	0.00204	CcSEcCtD
Olopatadine—Dizziness—Rivastigmine—Alzheimer's disease	0.000221	0.00201	CcSEcCtD
Olopatadine—Vomiting—Memantine—Alzheimer's disease	0.000217	0.00198	CcSEcCtD
Olopatadine—Rash—Memantine—Alzheimer's disease	0.000215	0.00196	CcSEcCtD
Olopatadine—Dermatitis—Memantine—Alzheimer's disease	0.000215	0.00196	CcSEcCtD
Olopatadine—Headache—Memantine—Alzheimer's disease	0.000214	0.00195	CcSEcCtD
Olopatadine—Vomiting—Rivastigmine—Alzheimer's disease	0.000212	0.00194	CcSEcCtD
Olopatadine—Rash—Rivastigmine—Alzheimer's disease	0.00021	0.00192	CcSEcCtD
Olopatadine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00021	0.00192	CcSEcCtD
Olopatadine—Imipramine—HTR6—Alzheimer's disease	0.000209	0.0461	CrCbGaD
Olopatadine—Headache—Rivastigmine—Alzheimer's disease	0.000209	0.00191	CcSEcCtD
Olopatadine—Amitriptyline—HTR6—Alzheimer's disease	0.000208	0.0458	CrCbGaD
Olopatadine—Nausea—Memantine—Alzheimer's disease	0.000202	0.00185	CcSEcCtD
Olopatadine—Nausea—Rivastigmine—Alzheimer's disease	0.000198	0.00181	CcSEcCtD
Olopatadine—Cyclobenzaprine—HTR2A—Alzheimer's disease	0.000172	0.0378	CrCbGaD
Olopatadine—Cyclobenzaprine—CYP2D6—Alzheimer's disease	0.000157	0.0346	CrCbGaD
Olopatadine—Acepromazine—HTR2A—Alzheimer's disease	0.000119	0.0261	CrCbGaD
Olopatadine—Nortriptyline—PTGS1—Alzheimer's disease	0.000119	0.0261	CrCbGaD
Olopatadine—Clomipramine—SLC6A4—Alzheimer's disease	0.000117	0.0258	CrCbGaD
Olopatadine—Nortriptyline—SLC6A4—Alzheimer's disease	0.000115	0.0253	CrCbGaD
Olopatadine—Thiothixene—HTR2A—Alzheimer's disease	0.000114	0.0251	CrCbGaD
Olopatadine—Thiothixene—CYP2D6—Alzheimer's disease	0.000104	0.023	CrCbGaD
Olopatadine—Doxepin—SLC6A4—Alzheimer's disease	0.000103	0.0227	CrCbGaD
Olopatadine—Clomipramine—HTR2A—Alzheimer's disease	9.03e-05	0.0199	CrCbGaD
Olopatadine—Chlorprothixene—HTR2A—Alzheimer's disease	8.99e-05	0.0198	CrCbGaD
Olopatadine—Nortriptyline—HTR2A—Alzheimer's disease	8.82e-05	0.0194	CrCbGaD
Olopatadine—Clomipramine—CYP2D6—Alzheimer's disease	8.26e-05	0.0182	CrCbGaD
Olopatadine—Nortriptyline—CYP2D6—Alzheimer's disease	8.07e-05	0.0177	CrCbGaD
Olopatadine—Imipramine—SLC6A4—Alzheimer's disease	8.02e-05	0.0176	CrCbGaD
Olopatadine—Amitriptyline—SLC6A4—Alzheimer's disease	7.97e-05	0.0175	CrCbGaD
Olopatadine—Doxepin—HTR2A—Alzheimer's disease	7.92e-05	0.0174	CrCbGaD
Olopatadine—Doxepin—CYP2D6—Alzheimer's disease	7.24e-05	0.0159	CrCbGaD
Olopatadine—Imipramine—HTR2A—Alzheimer's disease	6.16e-05	0.0135	CrCbGaD
Olopatadine—Amitriptyline—HTR2A—Alzheimer's disease	6.12e-05	0.0135	CrCbGaD
Olopatadine—Imipramine—CYP2D6—Alzheimer's disease	5.63e-05	0.0124	CrCbGaD
Olopatadine—Amitriptyline—CYP2D6—Alzheimer's disease	5.6e-05	0.0123	CrCbGaD
Olopatadine—S100B—Immune System—GAB2—Alzheimer's disease	4.91e-05	0.000441	CbGpPWpGaD
Olopatadine—S100B—Immune System—GSK3A—Alzheimer's disease	4.87e-05	0.000437	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NCSTN—Alzheimer's disease	4.86e-05	0.000436	CbGpPWpGaD
Olopatadine—S100B—Immune System—APP—Alzheimer's disease	4.79e-05	0.000429	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	4.77e-05	0.000428	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	4.76e-05	0.000426	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LRP1—Alzheimer's disease	4.74e-05	0.000425	CbGpPWpGaD
Olopatadine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	4.66e-05	0.000418	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GFAP—Alzheimer's disease	4.63e-05	0.000416	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GAL—Alzheimer's disease	4.63e-05	0.000416	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—GSK3B—Alzheimer's disease	4.53e-05	0.000406	CbGpPWpGaD
Olopatadine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	4.5e-05	0.000404	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CREB1—Alzheimer's disease	4.49e-05	0.000403	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	4.4e-05	0.000395	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—GSK3B—Alzheimer's disease	4.28e-05	0.000384	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GAL—Alzheimer's disease	4.27e-05	0.000383	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CREB1—Alzheimer's disease	4.25e-05	0.000381	CbGpPWpGaD
Olopatadine—S100A12—Immune System—S100B—Alzheimer's disease	4.12e-05	0.000369	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—A2M—Alzheimer's disease	4.08e-05	0.000366	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	4.03e-05	0.000361	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PSEN2—Alzheimer's disease	3.96e-05	0.000355	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	3.84e-05	0.000345	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—BCL2—Alzheimer's disease	3.77e-05	0.000338	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	3.74e-05	0.000336	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1A—Alzheimer's disease	3.72e-05	0.000334	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—HTR2A—Alzheimer's disease	3.66e-05	0.000328	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NPY—Alzheimer's disease	3.64e-05	0.000326	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IAPP—Alzheimer's disease	3.62e-05	0.000324	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MEF2C—Alzheimer's disease	3.6e-05	0.000323	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AGER—Alzheimer's disease	3.57e-05	0.00032	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—BCL2—Alzheimer's disease	3.57e-05	0.00032	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PRKCG—Alzheimer's disease	3.53e-05	0.000317	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1A—Alzheimer's disease	3.52e-05	0.000316	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CRH—Alzheimer's disease	3.51e-05	0.000315	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PYY—Alzheimer's disease	3.48e-05	0.000312	CbGpPWpGaD
Olopatadine—S100B—Immune System—MEF2C—Alzheimer's disease	3.41e-05	0.000305	CbGpPWpGaD
Olopatadine—S100B—Immune System—AGER—Alzheimer's disease	3.38e-05	0.000303	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—NPY—Alzheimer's disease	3.35e-05	0.000301	CbGpPWpGaD
Olopatadine—S100B—Immune System—PRKCG—Alzheimer's disease	3.34e-05	0.0003	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—IAPP—Alzheimer's disease	3.33e-05	0.000299	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.33e-05	0.000299	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NPS—Alzheimer's disease	3.33e-05	0.000299	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PPP3CA—Alzheimer's disease	3.31e-05	0.000297	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	3.27e-05	0.000293	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTK2B—Alzheimer's disease	3.27e-05	0.000293	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CRH—Alzheimer's disease	3.24e-05	0.00029	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—F2—Alzheimer's disease	3.21e-05	0.000288	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NTRK2—Alzheimer's disease	3.18e-05	0.000285	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SST—Alzheimer's disease	3.18e-05	0.000285	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GAB2—Alzheimer's disease	3.18e-05	0.000285	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—AKT1—Alzheimer's disease	3.16e-05	0.000284	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PYY—Alzheimer's disease	3.16e-05	0.000283	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GSK3A—Alzheimer's disease	3.15e-05	0.000282	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APP—Alzheimer's disease	3.1e-05	0.000278	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—NPS—Alzheimer's disease	3.07e-05	0.000275	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—MAPK8—Alzheimer's disease	3.06e-05	0.000274	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CALM1—Alzheimer's disease	3.06e-05	0.000274	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SST—Alzheimer's disease	2.93e-05	0.000262	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PLCB1—Alzheimer's disease	2.92e-05	0.000262	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR6—Alzheimer's disease	2.91e-05	0.000261	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—MAPK8—Alzheimer's disease	2.89e-05	0.000259	CbGpPWpGaD
Olopatadine—S100B—Immune System—CALM1—Alzheimer's disease	2.89e-05	0.000259	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	2.89e-05	0.000259	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	2.87e-05	0.000257	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—APP—Alzheimer's disease	2.85e-05	0.000256	CbGpPWpGaD
Olopatadine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	2.83e-05	0.000254	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CDK5—Alzheimer's disease	2.74e-05	0.000246	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGFR—Alzheimer's disease	2.73e-05	0.000244	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ADAM10—Alzheimer's disease	2.66e-05	0.000239	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR6—Alzheimer's disease	2.64e-05	0.000237	CbGpPWpGaD
Olopatadine—S100A12—Immune System—GSK3B—Alzheimer's disease	2.64e-05	0.000237	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CREB1—Alzheimer's disease	2.62e-05	0.000235	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	2.61e-05	0.000234	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.53e-05	0.000226	CbGpPWpGaD
Olopatadine—S100B—Immune System—GSK3B—Alzheimer's disease	2.49e-05	0.000224	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.48e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	2.48e-05	0.000222	CbGpPWpGaD
Olopatadine—S100B—Immune System—CREB1—Alzheimer's disease	2.47e-05	0.000222	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.44e-05	0.000219	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	2.42e-05	0.000217	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GAL—Alzheimer's disease	2.41e-05	0.000216	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF2—Alzheimer's disease	2.4e-05	0.000215	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1R—Alzheimer's disease	2.32e-05	0.000208	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LPL—Alzheimer's disease	2.22e-05	0.000199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MEF2C—Alzheimer's disease	2.2e-05	0.000197	CbGpPWpGaD
Olopatadine—S100A12—Immune System—BCL2—Alzheimer's disease	2.2e-05	0.000197	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GAL—Alzheimer's disease	2.19e-05	0.000196	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRKCG—Alzheimer's disease	2.16e-05	0.000194	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TTR—Alzheimer's disease	2.14e-05	0.000192	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	2.12e-05	0.00019	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NGF—Alzheimer's disease	2.1e-05	0.000189	CbGpPWpGaD
Olopatadine—S100B—Immune System—BCL2—Alzheimer's disease	2.08e-05	0.000186	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCR5—Alzheimer's disease	2.05e-05	0.000184	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HTR2A—Alzheimer's disease	2e-05	0.00018	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—IL6—Alzheimer's disease	1.95e-05	0.000175	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL1B—Alzheimer's disease	1.94e-05	0.000174	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—NPY—Alzheimer's disease	1.9e-05	0.00017	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	1.89e-05	0.00017	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—Alzheimer's disease	1.89e-05	0.000169	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IAPP—Alzheimer's disease	1.88e-05	0.000169	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CALM1—Alzheimer's disease	1.87e-05	0.000168	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PYY—Alzheimer's disease	1.87e-05	0.000167	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LEP—Alzheimer's disease	1.86e-05	0.000167	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—Alzheimer's disease	1.86e-05	0.000167	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—Alzheimer's disease	1.85e-05	0.000166	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—HTR2A—Alzheimer's disease	1.85e-05	0.000165	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CAV1—Alzheimer's disease	1.84e-05	0.000165	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL1B—Alzheimer's disease	1.84e-05	0.000165	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CRH—Alzheimer's disease	1.83e-05	0.000164	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—Alzheimer's disease	1.8e-05	0.000161	CbGpPWpGaD
Olopatadine—S100A12—Immune System—MAPK8—Alzheimer's disease	1.78e-05	0.00016	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—ESR1—Alzheimer's disease	1.78e-05	0.000159	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—F2—Alzheimer's disease	1.76e-05	0.000157	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—NPS—Alzheimer's disease	1.73e-05	0.000155	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NPY—Alzheimer's disease	1.72e-05	0.000154	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH1—Alzheimer's disease	1.72e-05	0.000154	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IAPP—Alzheimer's disease	1.71e-05	0.000153	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—Alzheimer's disease	1.7e-05	0.000153	CbGpPWpGaD
Olopatadine—S100B—Immune System—MAPK8—Alzheimer's disease	1.68e-05	0.000151	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CRH—Alzheimer's disease	1.66e-05	0.000149	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GAB2—Alzheimer's disease	1.65e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SST—Alzheimer's disease	1.65e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDK5—Alzheimer's disease	1.62e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—F2—Alzheimer's disease	1.62e-05	0.000145	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GSK3B—Alzheimer's disease	1.61e-05	0.000145	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—APP—Alzheimer's disease	1.61e-05	0.000145	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CREB1—Alzheimer's disease	1.6e-05	0.000143	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INS—Alzheimer's disease	1.59e-05	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NPS—Alzheimer's disease	1.57e-05	0.000141	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PPP3CA—Alzheimer's disease	1.57e-05	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL2—Alzheimer's disease	1.57e-05	0.00014	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR6—Alzheimer's disease	1.56e-05	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1—Alzheimer's disease	1.54e-05	0.000138	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PLCB1—Alzheimer's disease	1.52e-05	0.000136	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GAB2—Alzheimer's disease	1.5e-05	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SST—Alzheimer's disease	1.5e-05	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—APP—Alzheimer's disease	1.46e-05	0.000131	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL2—Alzheimer's disease	1.44e-05	0.000129	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.43e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSENEN—Alzheimer's disease	1.42e-05	0.000127	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APH1A—Alzheimer's disease	1.4e-05	0.000125	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—Alzheimer's disease	1.4e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PLCB1—Alzheimer's disease	1.38e-05	0.000124	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NCSTN—Alzheimer's disease	1.36e-05	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LRP1—Alzheimer's disease	1.33e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GAL—Alzheimer's disease	1.29e-05	0.000116	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GFAP—Alzheimer's disease	1.29e-05	0.000116	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.22e-05	0.000109	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—Alzheimer's disease	1.18e-05	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.14e-05	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—A2M—Alzheimer's disease	1.14e-05	0.000102	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—Alzheimer's disease	1.14e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	1.14e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCG—Alzheimer's disease	1.12e-05	0.000101	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSEN2—Alzheimer's disease	1.1e-05	9.91e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MAPK8—Alzheimer's disease	1.09e-05	9.76e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.09e-05	9.73e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—Alzheimer's disease	1.08e-05	9.64e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—Alzheimer's disease	1.07e-05	9.56e-05	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—Alzheimer's disease	1.05e-05	9.41e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2A—Alzheimer's disease	1.04e-05	9.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.04e-05	9.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCG—Alzheimer's disease	1.02e-05	9.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPY—Alzheimer's disease	1.02e-05	9.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IAPP—Alzheimer's disease	1.01e-05	9.06e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—Alzheimer's disease	1.01e-05	9.01e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	9.92e-06	8.9e-05	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—Alzheimer's disease	9.92e-06	8.89e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CRH—Alzheimer's disease	9.81e-06	8.8e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—Alzheimer's disease	9.68e-06	8.68e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	9.55e-06	8.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2A—Alzheimer's disease	9.47e-06	8.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NPS—Alzheimer's disease	9.3e-06	8.34e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP3CA—Alzheimer's disease	9.25e-06	8.3e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ND1—Alzheimer's disease	9.23e-06	8.27e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—Alzheimer's disease	9.22e-06	8.27e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—F2—Alzheimer's disease	9.14e-06	8.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTK2B—Alzheimer's disease	9.12e-06	8.18e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GAB2—Alzheimer's disease	8.87e-06	7.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SST—Alzheimer's disease	8.87e-06	7.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NTRK2—Alzheimer's disease	8.87e-06	7.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CALM1—Alzheimer's disease	8.83e-06	7.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GSK3A—Alzheimer's disease	8.79e-06	7.88e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APP—Alzheimer's disease	8.64e-06	7.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—F2—Alzheimer's disease	8.3e-06	7.44e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLCB1—Alzheimer's disease	8.16e-06	7.31e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGFR—Alzheimer's disease	7.61e-06	6.82e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—Alzheimer's disease	7.59e-06	6.81e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CREB1—Alzheimer's disease	7.56e-06	6.78e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADAM10—Alzheimer's disease	7.43e-06	6.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—Alzheimer's disease	7.4e-06	6.64e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—S100B—Alzheimer's disease	7.03e-06	6.3e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—Alzheimer's disease	6.95e-06	6.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—Alzheimer's disease	6.69e-06	6e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1R—Alzheimer's disease	6.47e-06	5.8e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—Alzheimer's disease	6.41e-06	5.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LPL—Alzheimer's disease	6.2e-06	5.56e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	6.15e-06	5.51e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	6.03e-06	5.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	5.95e-06	5.33e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	5.95e-06	5.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NGF—Alzheimer's disease	5.88e-06	5.27e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	5.72e-06	5.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	5.7e-06	5.11e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	5.59e-06	5.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	5.49e-06	4.92e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—A2M—Alzheimer's disease	5.3e-06	4.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	5.22e-06	4.68e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	5.2e-06	4.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	5.2e-06	4.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	5.15e-06	4.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.97e-06	4.45e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.9e-06	4.4e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.8e-06	4.3e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	4.61e-06	4.13e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	4.56e-06	4.09e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	4.5e-06	4.04e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	4.47e-06	4.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INS—Alzheimer's disease	4.44e-06	3.98e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	4.37e-06	3.92e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.32e-06	3.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.32e-06	3.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	4.3e-06	3.85e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.24e-06	3.8e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.02e-06	3.6e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.9e-06	3.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	3.79e-06	3.4e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	3.67e-06	3.29e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.34e-06	2.99e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	3.31e-06	2.97e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	3.29e-06	2.95e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.17e-06	2.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.15e-06	2.83e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	3.04e-06	2.73e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	3.03e-06	2.72e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.88e-06	2.58e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.81e-06	2.52e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.59e-06	2.33e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.58e-06	2.31e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.42e-06	2.17e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.42e-06	2.17e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.39e-06	2.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	2.12e-06	1.9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.1e-06	1.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INS—Alzheimer's disease	2.06e-06	1.85e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.94e-06	1.74e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.81e-06	1.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.79e-06	1.61e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.66e-06	1.48e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	8.32e-07	7.46e-06	CbGpPWpGaD
